Historical record - last NADAC effective date: 5/20/2015
Product Information
IRBESARTAN 300 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.3358 per EA under NDC 65862063905. Its NADAC has been published 78 times since Nov 28, 2013.
FDA first approved this application on Sep 27, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862063905
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/20/2015
Active Ingredients
IRBESARTANApproval Type
Generic (ANDA)
FDA Application
ANDA203081FDA Approved
9/27/2012
TE Code
AB
On Market Since
9/27/2012
Pharmacological Classes
Price Statistics
The NADAC for IRBESARTAN 300 MG TABLET has been published 78 times since Nov 28, 2013, and over the history we have for it it has declined 4.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3358 per EA |
|---|---|
| All-time high | $0.3709 (Mar 12, 2014) |
| All-time low | $0.3088 (Jan 21, 2015) |
| Median price | $0.3431 |
| Average price | $0.3420 |
| Largest weekly change | +13.7% (Feb 18, 2015) |
| Weeks tracked | 78 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-4.2%
Last surveyed May 20, 2015 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 54% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IRBESARTAN 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IRBESARTAN 300 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.3358 per EA (NDC 65862063905), effective May 20, 2015.
How has the price of IRBESARTAN 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for IRBESARTAN 300 MG TABLET has declined 4.2%. It has been tracked across 78 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for IRBESARTAN 300 MG TABLET?
Since Nov 28, 2013, the NADAC for IRBESARTAN 300 MG TABLET has ranged from a low of $0.3088 (Jan 21, 2015) to a high of $0.3709 (Mar 12, 2014), with a median of $0.3431 per EA.
Are there cheaper alternatives to IRBESARTAN 300 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IRBESARTAN 300 MG TABLET, is $0.1555 per EA — about 54% below IRBESARTAN 300 MG TABLET.
Who manufactures IRBESARTAN 300 MG TABLET?
IRBESARTAN 300 MG TABLET (NDC 65862063905) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.